Palmieri, D. ., Rangachari, A. ., & Butterfield, D. . (1990). Effects of domain-specific erythrocyte membrane modulators on acetylcholinesterase and NADH:cytochrome b5 reductase activities. Archives of Biochemistry and Biophysics, 280(1), 224-8. https://doi.org/10.1016/0003-9861(90)90540-f

Palmieri, D. ., & Butterfield, D. . (1990). Structure-activity investigation of the alteration of the physical state of the skeletal network of proteins in human erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridine. Biochimica Et Biophysica Acta, 1024(2), 285-8. https://doi.org/10.1016/0005-2736(90)90356-s (Original work published 1990)

Butterfield, D. ., & Palmieri, D. . Spin-labelling studies of the interaction of 9-amino-1,2,3,4-tetrahydroacridine (THA), a proposed drug for the treatment of Alzheimer’s disease, with erythrocyte membranes. Free Radical Research Communications, 9(3-6), 361-6. https://doi.org/10.3109/10715769009145695 (Original work published 1990)

Palmieri, D. ., Jacob, R. ., & Butterfield, D. . (1989). Morphological alterations in erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridine and 9-aminoacridine. Biochemical and Biophysical Research Communications, 163(3), 1351-5. https://doi.org/10.1016/0006-291x(89)91127-3 (Original work published 1989)

Palmieri, D. ., & Butterfield, D. . Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA), a potential drug for treatment of Alzheimer’s disease, on the physical state of human erythrocyte membranes. Progress in Clinical and Biological Research, 292, 419-24. (Original work published 1989)